Successful Treatment of Cutaneous Manifestations of Blau Syndrome with UVA-1 Phototherapy in a Paediatric Patient
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0428Keywords:
Blau Syndrome, UVA-1Phototherapy, Pediatrics, Granulomatous Skin Disease, UVA-1Downloads
References
Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev 2012; 12: 44–51. DOI: https://doi.org/10.1016/j.autrev.2012.07.028
Zhong Z, Ding J, Su G, Liao W, Gao Y, Zhu Y, et al. Genetic and clinical features of Blau syndrome among Chinese patients with uveitis. Ophthalmology 2022; 129: 821–828. DOI: https://doi.org/10.1016/j.ophtha.2022.03.014
Lassoued Ferjani H, Kharrat L, Ben Nessib D, Kaffel D, Maatallah K, Hamdi W. Management of Blau syndrome: review and proposal of a treatment algorithm. Eur J Pediatr 2024; 183: 1–7. DOI: https://doi.org/10.1007/s00431-023-05204-9
Jensen ME, Harrell K, McBride JD. Case report: methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome. Front Immunol 2023; 14: 1279329. DOI: https://doi.org/10.3389/fimmu.2023.1279329
Schnopp C, Tzaneva S, Mempel M, Schulmeister K, Abeck D, Tanew A. UVA1 phototherapy for disseminated granuloma annulare. Photodermatol Photoimmunol Photomed 2005; 21: 68–71. DOI: https://doi.org/10.1111/j.1600-0781.2005.00145.x
Lima AL, Goetze S, Illing T, Elsner P. Light and laser modalities in the treatment of cutaneous sarcoidosis: a systematic review. Acta Derm Venereol 2018; 98: 481–483. DOI: https://doi.org/10.2340/00015555-2864
Poline J, Fogel O, Pajot C, Miceli‐Richard C, Rybojad M, Galeotti C, et al. Early‐onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome. Acad Dermatol Venereol 2020; 34: 340–348. DOI: https://doi.org/10.1111/jdv.15963
Stoevesandt J, Morbach H, Martin TM, Zierhut M, Girschick H, Hamm H. Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol 2010; 27: 69–73. DOI: https://doi.org/10.1111/j.1525-1470.2009.01060.x
Kaufman KP, Becker ML. Distinguishing Blau syndrome from systemic sarcoidosis. Curr Allergy Asthma Rep 2021; 21: 10. DOI: https://doi.org/10.1007/s11882-021-00991-3
Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev 2014; 13: 1220–1229. DOI: https://doi.org/10.1016/j.autrev.2014.08.010
Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis 2020; 79: 1492–1499. DOI: https://doi.org/10.1136/annrheumdis-2020-217320
Matsuda T, Kambe N, Takimoto-Ito R, Ueki Y, Nakamizo S, Saito MK, et al. Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis. Front Immunol 2022; 13: 895765. DOI: https://doi.org/10.3389/fimmu.2022.895765
Graefe T, Konrad H, Barta U, Wollina U, Elsner P. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001; 145: 354–355. DOI: https://doi.org/10.1046/j.1365-2133.2001.04356.x
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
